Here, we were able to show that a large fraction of convalescent COVID-19 patients has specific T cells reactive against PepTivator SARS-CoV-2 Select and that these T cells could be magnetically enriched to high purities via IFN-γ CSA. The gene discussed is IFNG; the disease is COVID-19.